title: Development of the Facial Lines Treatment Satisfaction Questionnaire and initial results for botulinum toxin type A-treated patients.
abstract: BACKGROUND
  Botulinum toxin type A treatment is a safe and effective treatment for facial lines. Patient satisfaction with treatment has not yet been systematically measured and reported.
  
  
  OBJECTIVE
  To create a valid and reliable questionnaire to assess patient satisfaction with facial line treatment and to assess treatment satisfaction in facial line patients.
  
  
  METHODS
  Development of the Facial Line Treatment Satisfaction (FTS) Questionnaire followed the five-step process recommended by the Patient Reported Outcomes Harmonization Committee.
  
  
  RESULTS
  One hundred fifty-two pilot test participants received botulinum toxin type A treatment alone or in combination with a minimally invasive facial line treatment and were satisfied or very satisfied with their facial lines treatment.
  
  
  CONCLUSIONS
  The FTS is a valid and reliable 14-item questionnaire that measures an aesthetic patient's satisfaction with facial line treatment. The FTS can be used in clinical practice or clinical trials of facial line treatments. Botulinum toxin type A treatment is associated with high patient satisfaction.
authors.affiliation: Aesthetic Solutions and University of North Carolina, Chapel Hill 27517, USA. cscnc@mindspring.com
authors.forename: Sue Ellen
authors.initials: SE
authors.lastname: Cox
authors.forename: J Charlie
authors.initials: JC
authors.lastname: Finn
authors.forename: Lori
authors.initials: L
authors.lastname: Stetler
authors.forename: John
authors.initials: J
authors.lastname: Mackowiak
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Kowalski
mesh_terms: D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D017060:Patient Satisfaction; D010865:Pilot Projects; D015203:Reproducibility of Results; D015595:Skin Aging / Q000187:drug effects*; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A